These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 31667675

  • 21. Multi-Atlas-Based Attenuation Correction for Brain 18F-FDG PET Imaging Using a Time-of-Flight PET/MR Scanner: Comparison with Clinical Single-Atlas- and CT-Based Attenuation Correction.
    Sekine T, Burgos N, Warnock G, Huellner M, Buck A, Ter Voert EE, Cardoso MJ, Hutton BF, Ourselin S, Veit-Haibach P, Delso G.
    J Nucl Med; 2016 Aug; 57(8):1258-64. PubMed ID: 27013697
    [Abstract] [Full Text] [Related]

  • 22. MR-based attenuation correction for cardiac FDG PET on a hybrid PET/MRI scanner: comparison with standard CT attenuation correction.
    Vontobel J, Liga R, Possner M, Clerc OF, Mikulicic F, Veit-Haibach P, Ter Voert EE, Fuchs TA, Stehli J, Pazhenkottil AP, Benz DC, Gräni C, Gaemperli O, Herzog B, Buechel RR, Kaufmann PA.
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1574-80. PubMed ID: 26091704
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of a 2D UNet-Based Attenuation Correction Methodology for PET/MR Brain Studies.
    Presotto L, Bettinardi V, Bagnalasta M, Scifo P, Savi A, Vanoli EG, Fallanca F, Picchio M, Perani D, Gianolli L, De Bernardi E.
    J Digit Imaging; 2022 Jun; 35(3):432-445. PubMed ID: 35091873
    [Abstract] [Full Text] [Related]

  • 24. Predictive Value of 18F-Sodium Fluoride Positron Emission Tomography in Detecting High-Risk Coronary Artery Disease in Combination With Computed Tomography.
    Kitagawa T, Yamamoto H, Nakamoto Y, Sasaki K, Toshimitsu S, Tatsugami F, Awai K, Hirokawa Y, Kihara Y.
    J Am Heart Assoc; 2018 Oct 16; 7(20):e010224. PubMed ID: 30371290
    [Abstract] [Full Text] [Related]

  • 25. Clinical Evaluation of Zero-Echo-Time Attenuation Correction for Brain 18F-FDG PET/MRI: Comparison with Atlas Attenuation Correction.
    Sekine T, Ter Voert EE, Warnock G, Buck A, Huellner M, Veit-Haibach P, Delso G.
    J Nucl Med; 2016 Dec 16; 57(12):1927-1932. PubMed ID: 27339875
    [Abstract] [Full Text] [Related]

  • 26. Simultaneous carotid PET/MR: feasibility and improvement of magnetic resonance-based attenuation correction.
    Bini J, Eldib M, Robson PM, Calcagno C, Fayad ZA.
    Int J Cardiovasc Imaging; 2016 Jan 16; 32(1):61-71. PubMed ID: 25898892
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of Sinus/Edge-Corrected Zero-Echo-Time-Based Attenuation Correction in Brain PET/MRI.
    Yang J, Wiesinger F, Kaushik S, Shanbhag D, Hope TA, Larson PEZ, Seo Y.
    J Nucl Med; 2017 Nov 16; 58(11):1873-1879. PubMed ID: 28473594
    [Abstract] [Full Text] [Related]

  • 28. Magnetic resonance-based attenuation correction for PET/MR hybrid imaging using continuous valued attenuation maps.
    Navalpakkam BK, Braun H, Kuwert T, Quick HH.
    Invest Radiol; 2013 May 16; 48(5):323-32. PubMed ID: 23442772
    [Abstract] [Full Text] [Related]

  • 29. MR-based attenuation correction for PET/MRI neurological studies with continuous-valued attenuation coefficients for bone through a conversion from R2* to CT-Hounsfield units.
    Juttukonda MR, Mersereau BG, Chen Y, Su Y, Rubin BG, Benzinger TLS, Lalush DS, An H.
    Neuroimage; 2015 May 15; 112():160-168. PubMed ID: 25776213
    [Abstract] [Full Text] [Related]

  • 30. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M, Takei T, Souvatzoglou M, Mayerhoefer ME, Fürst S, Gaertner FC, Loeffelbein DJ, Rummeny EJ, Ziegler SI, Schwaiger M, Beer AJ.
    J Nucl Med; 2014 Feb 15; 55(2):191-7. PubMed ID: 24309383
    [Abstract] [Full Text] [Related]

  • 31. Utility of 18F-fluorodeoxy glucose and 18F-sodium fluoride positron emission tomography/computed tomography in the diagnosis of medication-related osteonecrosis of the jaw: A preclinical study in a rat model.
    Kim Y, Lee HY, Yoon HJ, Kim BS.
    J Craniomaxillofac Surg; 2016 Apr 15; 44(4):357-63. PubMed ID: 26880011
    [Abstract] [Full Text] [Related]

  • 32. Feasibility of simultaneous 18F-FDG PET/MRI for the quantitative volumetric and metabolic measurements of abdominal fat tissues using fat segmentation.
    Im HJ, Paeng JC, Cheon GJ, Kim EE, Lee JS, Goo JM, Kang KW, Chung JK, Lee DS.
    Nucl Med Commun; 2016 Jun 15; 37(6):616-22. PubMed ID: 26836629
    [Abstract] [Full Text] [Related]

  • 33. Gadolinium-based contrast agent attenuation does not impact PET quantification in simultaneous dynamic contrast enhanced breast PET/MR.
    Allen TJ, Henze Bancroft LC, Kumar M, Bradshaw TJ, Strigel RM, McMillan AB, Fowler AM.
    Med Phys; 2022 Aug 15; 49(8):5206-5215. PubMed ID: 35621727
    [Abstract] [Full Text] [Related]

  • 34. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H, Rominger A, Walter L, Habs M, Volpers S, Hacker M, Reiser MF, Bartenstein P, Saam T.
    Int J Cardiovasc Imaging; 2016 Jan 15; 32(1):49-59. PubMed ID: 25898891
    [Abstract] [Full Text] [Related]

  • 35. Hybrid PET/CT and PET/MRI imaging of vulnerable coronary plaque and myocardial scar tissue in acute myocardial infarction.
    Marchesseau S, Seneviratna A, Sjöholm AT, Qin DL, Ho JXM, Hausenloy DJ, Townsend DW, Richards AM, Totman JJ, Chan MYY.
    J Nucl Cardiol; 2018 Dec 15; 25(6):2001-2011. PubMed ID: 28500539
    [Abstract] [Full Text] [Related]

  • 36. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C, Raderer M, Karanikas G, Weber M, Kiesewetter B, Dolak W, Simonitsch-Klupp I, Mayerhoefer ME.
    Invest Radiol; 2016 Mar 15; 51(3):163-9. PubMed ID: 26784400
    [Abstract] [Full Text] [Related]

  • 37. Comparison of Positron Emission Tomography Quantification Using Magnetic Resonance- and Computed Tomography-Based Attenuation Correction in Physiological Tissues and Lesions: A Whole-Body Positron Emission Tomography/Magnetic Resonance Study in 66 Patients.
    Seith F, Gatidis S, Schmidt H, Bezrukov I, la Fougère C, Nikolaou K, Pfannenberg C, Schwenzer N.
    Invest Radiol; 2016 Jan 15; 51(1):66-71. PubMed ID: 26348596
    [Abstract] [Full Text] [Related]

  • 38. Impact of improved attenuation correction on 18F-FDG PET/MR hybrid imaging of the heart.
    Lindemann ME, Nensa F, Quick HH.
    PLoS One; 2019 Jan 15; 14(3):e0214095. PubMed ID: 30908507
    [Abstract] [Full Text] [Related]

  • 39. A multi-centre evaluation of eleven clinically feasible brain PET/MRI attenuation correction techniques using a large cohort of patients.
    Ladefoged CN, Law I, Anazodo U, St Lawrence K, Izquierdo-Garcia D, Catana C, Burgos N, Cardoso MJ, Ourselin S, Hutton B, Mérida I, Costes N, Hammers A, Benoit D, Holm S, Juttukonda M, An H, Cabello J, Lukas M, Nekolla S, Ziegler S, Fenchel M, Jakoby B, Casey ME, Benzinger T, Højgaard L, Hansen AE, Andersen FL.
    Neuroimage; 2017 Feb 15; 147():346-359. PubMed ID: 27988322
    [Abstract] [Full Text] [Related]

  • 40. AI-driven attenuation correction for brain PET/MRI: Clinical evaluation of a dementia cohort and importance of the training group size.
    Ladefoged CN, Hansen AE, Henriksen OM, Bruun FJ, Eikenes L, Øen SK, Karlberg A, Højgaard L, Law I, Andersen FL.
    Neuroimage; 2020 Nov 15; 222():117221. PubMed ID: 32750498
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.